Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

Fig. 3

Programmed death receptor 1 (PD-1) expression on CD4+ and CD8+ T cells in patients with CML receiving TKIs, either alone or in combination with IFN-α, and in healthy controls. PD-1 expression on CD4+ (a, b) and CD8+ T cells (c) from CML patients stratified by type of TKI used (imatinib or 2nd generation TKI). The p values in the figure reflect statistically significant differences among study groups

Back to article page
\